I wish them well. In the meantime, check out a company called Cellceutix (CTIX). They are in clinical trials wth terminal patients and are targeting the ‘angel’ gene as they call it. Multiple targets.
Yes, CTIX has made terrific progress so far in the Phase 1 trial. Hope the end results are successful
Been in it for over a year so far.....